Go Pro

Assenagon Asset Management S.A. Has $542.84 Million Stock Position in UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Assenagon Asset Management more than doubled its UnitedHealth Group stake by 121.7% in the second quarter, holding 1.31 million shares valued at approximately $542.8 million. Institutional investors collectively own 87.86% of UNH.
  • Analysts maintain a positive outlook, with an average rating of “Moderate Buy” and an average price target of $455.92; JPMorgan recently raised its target to $516.
  • UnitedHealth exceeded quarterly earnings expectations, reporting $6.38 in EPS versus the $4.94 consensus estimate, while raising its quarterly dividend to $2.32 per share—an annualized yield of about 2.3%.
  • MarketBeat previews top five stocks to own in September.

Assenagon Asset Management S.A. grew its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 121.7% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,306,053 shares of the healthcare conglomerate's stock after acquiring an additional 716,812 shares during the period. UnitedHealth Group accounts for about 0.7% of Assenagon Asset Management S.A.'s investment portfolio, making the stock its 19th biggest position. Assenagon Asset Management S.A. owned approximately 0.14% of UnitedHealth Group worth $542,835,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of UNH. Founders Capital Management LLC raised its position in shares of UnitedHealth Group by 3.0% during the fourth quarter. Founders Capital Management LLC now owns 982 shares of the healthcare conglomerate's stock worth $324,000 after acquiring an additional 29 shares during the last quarter. Kellett Wealth Advisors LLC increased its position in UnitedHealth Group by 1.7% in the fourth quarter. Kellett Wealth Advisors LLC now owns 1,746 shares of the healthcare conglomerate's stock worth $576,000 after purchasing an additional 29 shares during the period. Successful Portfolios LLC raised its holdings in UnitedHealth Group by 2.6% during the 4th quarter. Successful Portfolios LLC now owns 1,194 shares of the healthcare conglomerate's stock worth $411,000 after purchasing an additional 30 shares during the last quarter. Integral Investment Advisors Inc. boosted its stake in shares of UnitedHealth Group by 4.0% in the 2nd quarter. Integral Investment Advisors Inc. now owns 784 shares of the healthcare conglomerate's stock valued at $326,000 after purchasing an additional 30 shares during the last quarter. Finally, Bell Investment Advisors Inc raised its stake in shares of UnitedHealth Group by 14.4% during the first quarter. Bell Investment Advisors Inc now owns 246 shares of the healthcare conglomerate's stock worth $67,000 after buying an additional 31 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

UNH has been the topic of a number of recent research reports. JPMorgan Chase & Co. raised their price objective on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an "overweight" rating in a research note on Tuesday, July 21st. Piper Sandler set a $477.00 price target on UnitedHealth Group in a research note on Thursday, July 16th. Erste Group Bank raised UnitedHealth Group from a "hold" rating to a "buy" rating in a research note on Monday, April 27th. BMO Capital Markets set a $512.00 target price on UnitedHealth Group in a research report on Tuesday, July 21st. Finally, Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $397.00 to $485.00 and gave the company an "overweight" rating in a research report on Monday, July 13th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $455.92.

Read Our Latest Stock Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $403.94 on Friday. UnitedHealth Group Incorporated has a 12 month low of $239.50 and a 12 month high of $461.62. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $366.84 billion, a PE ratio of 25.99, a PEG ratio of 1.43 and a beta of 0.62. The stock's fifty day simple moving average is $413.55 and its 200 day simple moving average is $350.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group's revenue was up .4% compared to the same quarter last year. During the same quarter last year, the firm posted $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 19.69 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group's dividend payout ratio is currently 59.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines